2018-2023 Global Clinical Oncology Next Generation Sequencing (NGS) Market Report (Status and Outlook)

Publisher Name :
Date: 11-Oct-2018
No. of pages: 150

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Clinical Oncology Next Generation Sequencing (NGS) market for 2018-2023.

NGS allows the testing of all types of variants including single-nucleotide variations, insertions, deletions, exon duplications, gene copy number changes and translocations.

The key factor contributing to the growth of the NGS market is the improved understanding of the genetic markers of virulence and resistance.

Over the next five years, LPI(LP Information) projects that Clinical Oncology Next Generation Sequencing (NGS) will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Clinical Oncology Next Generation Sequencing (NGS) market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

- NGS Pre-Sequencing

- Sequencing

- Primary, Secondary & Tertiary Data Analysis

Segmentation by application:

- Academic & Clinical Research

- Hospitals & Clinics

- Pharma & Biotech Entities

We can also provide the customized separate regional or country-level reports, for the following regions:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

- Illumina

- Roche

- Agilent Technologies

- Knome

- Genomatix Software

- GATC Biotech

- Oxford Nanopore Technologies

- Macrogen

- Life Technologies

- DNASTAR

- Exosome Diagnostics

- Biomatters

- CLC Bio

- BGI

- Qiagen

- Perkin Elmer

- Pacific Bioscience

- Partek

- GnuBIO

- Foundation Medicine

- Paradigm

- Caris Life Sciences

- Myriad Genetics

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Clinical Oncology Next Generation Sequencing (NGS) market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

- To understand the structure of Clinical Oncology Next Generation Sequencing (NGS) market by identifying its various subsegments.

- Focuses on the key global Clinical Oncology Next Generation Sequencing (NGS) players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Clinical Oncology Next Generation Sequencing (NGS) with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the size of Clinical Oncology Next Generation Sequencing (NGS) submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

2018-2023 Global Clinical Oncology Next Generation Sequencing (NGS) Market Report (Status and Outlook)

Table of Contents

2018-2023 Global Clinical Oncology Next Generation Sequencing (NGS) Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size 2013-2023
2.1.2 Clinical Oncology Next Generation Sequencing (NGS) Market Size CAGR by Region
2.2 Clinical Oncology Next Generation Sequencing (NGS) Segment by Type
2.2.1 NGS Pre-Sequencing
2.2.2 Sequencing
2.2.3 NGS Data Analysis
2.2.4 Primary, Secondary & Tertiary Data Analysis
2.3 Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
2.3.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2013-2018)
2.3.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate by Type (2013-2018)
2.4 Clinical Oncology Next Generation Sequencing (NGS) Segment by Application
2.4.1 Academic & Clinical Research
2.4.2 Hospitals & Clinics
2.4.3 Pharma & Biotech Entities
2.5 Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
2.5.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2013-2018)
2.5.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate by Application (2013-2018)

3 Global Clinical Oncology Next Generation Sequencing (NGS) by Players
3.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Players
3.1.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Players (2016-2018)
3.1.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Players (2016-2018)
3.2 Global Clinical Oncology Next Generation Sequencing (NGS) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Clinical Oncology Next Generation Sequencing (NGS) by Regions
4.1 Clinical Oncology Next Generation Sequencing (NGS) Market Size by Regions
4.2 Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth
4.3 APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth
4.4 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth
4.5 Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth

5 Americas
5.1 Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size by Countries
5.2 Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
5.3 Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size by Countries
6.2 APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
6.3 APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Clinical Oncology Next Generation Sequencing (NGS) by Countries
7.2 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
7.3 Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) by Countries
8.2 Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type
8.3 Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Clinical Oncology Next Generation Sequencing (NGS) Market Forecast
10.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2018-2023)
10.2 Global Clinical Oncology Next Generation Sequencing (NGS) Forecast by Regions
10.2.1 Global Clinical Oncology Next Generation Sequencing (NGS) Forecast by Regions (2018-2023)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Clinical Oncology Next Generation Sequencing (NGS) Forecast by Type
10.8 Global Clinical Oncology Next Generation Sequencing (NGS) Forecast by Application

11 Key Players Analysis
11.1 Illumina
11.1.1 Company Details
11.1.2 Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.1.3 Illumina Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2018)
11.1.4 Main Business Overview
11.1.5 Illumina News
11.2 Roche
11.2.1 Company Details
11.2.2 Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.2.3 Roche Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2018)
11.2.4 Main Business Overview
11.2.5 Roche News
11.3 Agilent Technologies
11.3.1 Company Details
11.3.2 Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.3.3 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2018)
11.3.4 Main Business Overview
11.3.5 Agilent Technologies News
11.4 Knome
11.4.1 Company Details
11.4.2 Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.4.3 Knome Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2018)
11.4.4 Main Business Overview
11.4.5 Knome News
11.5 Genomatix Software
11.5.1 Company Details
11.5.2 Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.5.3 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2018)
11.5.4 Main Business Overview
11.5.5 Genomatix Software News
11.6 GATC Biotech
11.6.1 Company Details
11.6.2 Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.6.3 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2018)
11.6.4 Main Business Overview
11.6.5 GATC Biotech News
11.7 Oxford Nanopore Technologies
11.7.1 Company Details
11.7.2 Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.7.3 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2018)
11.7.4 Main Business Overview
11.7.5 Oxford Nanopore Technologies News
11.8 Macrogen
11.8.1 Company Details
11.8.2 Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.8.3 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2018)
11.8.4 Main Business Overview
11.8.5 Macrogen News
11.9 Life Technologies
11.9.1 Company Details
11.9.2 Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.9.3 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2018)
11.9.4 Main Business Overview
11.9.5 Life Technologies News
11.10 DNASTAR
11.10.1 Company Details
11.10.2 Clinical Oncology Next Generation Sequencing (NGS) Product Offered
11.10.3 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2018)
11.10.4 Main Business Overview
11.10.5 DNASTAR News
11.11 Exosome Diagnostics
11.12 Biomatters
11.13 CLC Bio
11.14 BGI
11.15 Qiagen
11.16 Perkin Elmer
11.17 Pacific Bioscience
11.18 Partek
11.19 GnuBIO
11.20 Foundation Medicine
11.21 Paradigm
11.22 Caris Life Sciences
11.23 Myriad Genetics

12 Research Findings and Conclusion

List of Tables and Figures

Table Product Specifications of Clinical Oncology Next Generation Sequencing (NGS)
Figure Clinical Oncology Next Generation Sequencing (NGS) Report Years Considered
Figure Market Research Methodology
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate 2013-2023 ($ Millions)
Table Clinical Oncology Next Generation Sequencing (NGS) Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of NGS Pre-Sequencing
Table Major Players of Sequencing
Table Major Players of NGS Data Analysis
Table Major Players of Primary, Secondary & Tertiary Data Analysis
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2013-2018)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2013-2018)
Figure Global NGS Pre-Sequencing Market Size Growth Rate
Figure Global Sequencing Market Size Growth Rate
Figure Global NGS Data Analysis Market Size Growth Rate
Figure Global Primary, Secondary & Tertiary Data Analysis Market Size Growth Rate
Figure Clinical Oncology Next Generation Sequencing (NGS) Consumed in Academic & Clinical Research
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market: Academic & Clinical Research (2013-2018) ($ Millions)
Figure Global Academic & Clinical Research YoY Growth ($ Millions)
Figure Clinical Oncology Next Generation Sequencing (NGS) Consumed in Hospitals & Clinics
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market: Hospitals & Clinics (2013-2018) ($ Millions)
Figure Global Hospitals & Clinics YoY Growth ($ Millions)
Figure Clinical Oncology Next Generation Sequencing (NGS) Consumed in Pharma & Biotech Entities
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market: Pharma & Biotech Entities (2013-2018) ($ Millions)
Figure Global Pharma & Biotech Entities YoY Growth ($ Millions)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2013-2018) ($ Millions)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2013-2018)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2013-2018)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size in Academic & Clinical Research Growth Rate
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size in Hospitals & Clinics Growth Rate
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size in Pharma & Biotech Entities Growth Rate
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue by Players (2016-2018) ($ Millions)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Players (2016-2018)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Players in 2017
Table Global Clinical Oncology Next Generation Sequencing (NGS) Key Players Head office and Products Offered
Table Clinical Oncology Next Generation Sequencing (NGS) Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size by Regions 2013-2018 ($ Millions)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Regions 2013-2018
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Regions 2013-2018
Figure Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size 2013-2018 ($ Millions)
Figure APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size 2013-2018 ($ Millions)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size 2013-2018 ($ Millions)
Table Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size by Countries (2013-2018) ($ Millions)
Table Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Countries (2013-2018)
Figure Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Countries in 2017
Table Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2013-2018) ($ Millions)
Table Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2013-2018)
Figure Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type in 2017
Table Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2013-2018) ($ Millions)
Table Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2013-2018)
Figure Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application in 2017
Figure United States Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure Canada Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Table APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size by Countries (2013-2018) ($ Millions)
Table APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Countries (2013-2018)
Figure APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Countries in 2017
Table APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2013-2018) ($ Millions)
Table APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2013-2018)
Figure APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type in 2017
Table APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2013-2018) ($ Millions)
Table APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2013-2018)
Figure APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application in 2017
Figure China Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure Korea Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure India Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure Australia Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Table Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Countries (2013-2018) ($ Millions)
Table Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Countries (2013-2018)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Countries in 2017
Table Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2013-2018) ($ Millions)
Table Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2013-2018)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type in 2017
Table Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2013-2018) ($ Millions)
Table Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2013-2018)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application in 2017
Figure Germany Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure France Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure UK Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure Italy Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure Russia Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure Spain Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Countries in 2017
Table Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Type in 2017
Table Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share by Application in 2017
Figure Egypt Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure Israel Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth 2013-2018 ($ Millions)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) arket Size Forecast (2018-2023) ($ Millions)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share Forecast by Regions
Figure Americas Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure APAC Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure United States Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Canada Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Mexico Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Brazil Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure China Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Japan Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Korea Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure India Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Australia Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Germany Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure France Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure UK Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Italy Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Russia Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Spain Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Egypt Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure South Africa Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Israel Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure Turkey Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Figure GCC Countries Clinical Oncology Next Generation Sequencing (NGS) Market Size 2018-2023 ($ Millions)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share Forecast by Type (2018-2023)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Market Share Forecast by Application (2018-2023)
Table Illumina Basic Information, Head Office, Major Market Areas and Its Competitors
Table Illumina Clinical Oncology Next Generation Sequencing (NGS) Revenue and Gross Margin (2016-2018)
Figure Illumina Clinical Oncology Next Generation Sequencing (NGS) Market Share (2016-2018)
Table Roche Basic Information, Head Office, Major Market Areas and Its Competitors
Table Roche Clinical Oncology Next Generation Sequencing (NGS) Revenue and Gross Margin (2016-2018)
Figure Roche Clinical Oncology Next Generation Sequencing (NGS) Market Share (2016-2018)
Table Agilent Technologies Basic Information, Head Office, Major Market Areas and Its Competitors
Table Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue and Gross Margin (2016-2018)
Figure Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Market Share (2016-2018)
Table Knome Basic Information, Head Office, Major Market Areas and Its Competitors
Table Knome Clinical Oncology Next Generation Sequencing (NGS) Revenue and Gross Margin (2016-2018)
Figure Knome Clinical Oncology Next Generation Sequencing (NGS) Market Share (2016-2018)
Table Genomatix Software Basic Information, Head Office, Major Market Areas and Its Competitors
Table Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Revenue and Gross Margin (2016-2018)
Figure Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Market Share (2016-2018)
Table GATC Biotech Basic Information, Head Office, Major Market Areas and Its Competitors
Table GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Revenue and Gross Margin (2016-2018)
Figure GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Market Share (2016-2018)
Table Oxford Nanopore Technologies Basic Information, Head Office, Major Market Areas and Its Competitors
Table Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue and Gross Margin (2016-2018)
Figure Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Market Share (2016-2018)
Table Macrogen Basic Information, Head Office, Major Market Areas and Its Competitors
Table Macrogen Clinical Oncology Next Generation Sequencing (NGS) Revenue and Gross Margin (2016-2018)
Figure Macrogen Clinical Oncology Next Generation Sequencing (NGS) Market Share (2016-2018)
Table Life Technologies Basic Information, Head Office, Major Market Areas and Its Competitors
Table Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue and Gross Margin (2016-2018)
Figure Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Market Share (2016-2018)
Table DNASTAR Basic Information, Head Office, Major Market Areas and Its Competitors
Table DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Revenue and Gross Margin (2016-2018)
Figure DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Market Share (2016-2018)
Table Exosome Diagnostics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Biomatters Basic Information, Head Office, Major Market Areas and Its Competitors
Table CLC Bio Basic Information, Head Office, Major Market Areas and Its Competitors
Table BGI Basic Information, Head Office, Major Market Areas and Its Competitors
Table Qiagen Basic Information, Head Office, Major Market Areas and Its Competitors
Table Perkin Elmer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Pacific Bioscience Basic Information, Head Office, Major Market Areas and Its Competitors
Table Partek Basic Information, Head Office, Major Market Areas and Its Competitors
Table GnuBIO Basic Information, Head Office, Major Market Areas and Its Competitors
Table Foundation Medicine Basic Information, Head Office, Major Market Areas and Its Competitors
Table Paradigm Basic Information, Head Office, Major Market Areas and Its Competitors
Table Caris Life Sciences Basic Information, Head Office, Major Market Areas and Its Competitors
Table Myriad Genetics Basic Information, Head Office, Major Market Areas and Its Competitors
  • Global Patient Chair Market Insights, Forecast to 2025
    Published: 17-Jun-2019        Price: US 4900 Onwards        Pages: 127
    Patient Chair is a kind of furniture designed for patients to get better care and rest. The global Patient Chair market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Patient Chair market based on company, product type, end user and key regions. This report studies the global market size of Patient Chair in key re......
  • Global Next Generation Sequencing (NGS) Sample Preparation Market Size, Status and Forecast 2019-2025
    Published: 17-Jun-2019        Price: US 3900 Onwards        Pages: 97
    In 2018, the global Next Generation Sequencing (NGS) Sample Preparation market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Next Generation Sequencing (NGS) Sample Preparation status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Next Generation Sequencing (NGS) Sample Preparation development in United States, E......
  • Global Hospital Consumables  Market Size, Status and Forecast 2019-2025
    Published: 17-Jun-2019        Price: US 3900 Onwards        Pages: 94
    In 2018, the global Hospital Consumables  market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Hospital Consumables  status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hospital Consumables  development in United States, Europe and China. The key players covered in this study - McKesson Me......
  • Global DNA and Gene Chips Market Size, Status and Forecast 2019-2025
    Published: 17-Jun-2019        Price: US 3900 Onwards        Pages: 99
    DNA microarrays are microscope slides that are printed with thousands of tiny spots in defined positions, with each spot containing a known DNA sequence or gene. Often, these slides are referred to as gene chips or DNA chips. In 2018, the global DNA and Gene Chips market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global DNA and Gene Chips status, future forecast, grow......
  • Global Synthetic Stem Cells Market Size, Status and Forecast 2019-2025
    Published: 17-Jun-2019        Price: US 3900 Onwards        Pages: 97
    Synthetic stem cells offer therapeutic benefits comparable to those from natural stem cells and could reduce some of the risks associated with stem cell therapies. Additionally, these cells have better preservation stability and the technology is generalizable to other types of stem cells. In 2018, the global Synthetic Stem Cells market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report foc......
  • Global Veterinary Telemedicine Market Size, Status and Forecast 2019-2025
    Published: 17-Jun-2019        Price: US 3900 Onwards        Pages: 97
    In 2018, the global Veterinary Telemedicine market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Veterinary Telemedicine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Veterinary Telemedicine development in United States, Europe and China. The key players covered in this study - Agora......
  • Global Medical Marijuana Packaging Market Size, Status and Forecast 2019-2025
    Published: 17-Jun-2019        Price: US 3900 Onwards        Pages: 93
    Medical Marijuana Packaging is a special packaging method under series strict laws and be used to transport medical marujuana safely. In 2018, the global Medical Marijuana Packaging market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Medical Marijuana Packaging status, future forecast, growth opportunity, key market and key players. The study objectives are to pr......
  • Global Dental Implant Prostheses Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 17-Jun-2019        Price: US 3480 Onwards        Pages: 135
    Dental Implant is an artificial tooth root that is placed into your jaw to hold a replacement tooth or bridge.A dental prosthesis may be held in place by connecting to teeth or dental implants, by suction, or by being held passively by surrounding muscles. Scope of the Report: The worldwide market for Dental Implant Prostheses is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a......
  • Global Blood and Fluid Warming Unit Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 17-Jun-2019        Price: US 3480 Onwards        Pages: 136
    Blood and Fluid Warming Unit is a medical device used in healthcare facilities for warming fluids or blood product,often it is used in emergency settings, operating rooms, and intensive care units to prevent hypothermia and increase comfort and drug absorption, the instrument warms blood to a temperature that is safe for infusion. Scope of the Report: The worldwide market for Blood and Fluid Warming Unit is expected to grow at a CAGR of roughly xx% over the next five years,......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs